{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:13:38Z","timestamp":1788880418482,"version":"build-2803163510"},"reference-count":107,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"\n Importance<\/jats:title>\n Pediatric obesity is a global health challenge. Although health behavior and lifestyle treatment (HBLT) is foundational, the comparative effectiveness of HBLT, various pharmacotherapies, and their combinations remains unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To compare the effectiveness of obesity management pharmacotherapies, structured lifestyle treatment, and their combinations on weight management outcomes in children and adolescents living with obesity.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n A systematic search was conducted in 4 electronic databases (Embase, CENTRAL, PsycINFO, and PubMed) from inception to June 17, 2025.<\/jats:p>\n <\/jats:sec>\n \n Data Selection<\/jats:title>\n Randomized clinical trials (RCTs) involving children and adolescents (aged 10-19 years) with obesity were selected. Interventions included lifestyle treatment (HBLT and counseling), obesity management pharmacotherapies (glucagon-like peptide-1 receptor agonists, metformin, orlistat, phentermine topiramate), or their combination vs control.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n \n Data were extracted and validity assessed according to\n PRISMA<\/jats:ext-link>\n guidelines. A random-effects network meta-analysis was used to pool data. Meta-regression was used to explore outcome moderators.\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n Primary outcomes were body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) and BMI\n z<\/jats:italic>\n score; secondary outcomes included waist circumference (WC), fat mass (FM), and lean mass (LM).\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 42 RCTs with 3835 participants (median [IQR] age, 14.5 [13.3-15.1] years; 2270 female [59.2%]) were included. Treatments combining pharmacotherapy and lifestyle treatment demonstrated the greatest efficacy across all adiposity-related outcomes. Semaglutide plus counseling was associated with the largest BMI reduction (mean difference, \u22128.31; 95% CI, \u221212.33 to \u22124.28) and BMI\n z<\/jats:italic>\n score reduction (mean difference, \u22121.80; 95% CI, \u22122.39 to \u22121.21), although this estimate was based on a limited number of studies. All pharmacological treatments were more effective when paired with lifestyle treatment, associated with significantly greater BMI and BMI\n z<\/jats:italic>\n score reductions than the same medications alone. Based on the primary analysis, HBLT as monotherapy was associated with substantial decreases in BMI (mean difference, \u22123.85; 95% CI, \u22124.91 to \u22122.80) and BMI\n z<\/jats:italic>\n score (mean difference, \u22120.89; 95% CI, \u22121.17 to \u22120.61) vs control.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n \n Finding of this systematic review and network meta-analysis suggest that combining lifestyle treatment with obesity management medications was associated with the greatest short-term (typically 6 to 12 months) weight reduction in adolescents with obesity. HBLT remained an indispensable component of any effective weight management, delivering meaningful weight loss and healthier body composition on its own. Combined with lifestyle treatment, pharmacotherapy was a key component, not solely an adjunct, associated with the greatest BMI and BMI\n z<\/jats:italic>\n score improvements, and long-term sustainability and safety were monitored.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapediatrics.2026.2248","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:30:57Z","timestamp":1782142257000},"page":"961","source":"Crossref","is-referenced-by-count":1,"title":["Obesity Management Pharmacotherapies and Lifestyle Treatment for Pediatric Obesity Management"],"prefix":"10.1001","volume":"180","author":[{"given":"Ke-wen","family":"Wan","sequence":"first","affiliation":[{"name":"Academy of Wellness and Human Development, Faculty of Arts and Social Sciences, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China"},{"name":"Dr Stephen Hui Research Centre for Physical Recreation and Wellness, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evander Fung-chau","family":"Lei","sequence":"additional","affiliation":[{"name":"Academy of Wellness and Human Development, Faculty of Arts and Social Sciences, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China"},{"name":"Dr Stephen Hui Research Centre for Physical Recreation and Wellness, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Academy of Wellness and Human Development, Faculty of Arts and Social Sciences, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asefa Adimasu","family":"Taddese","sequence":"additional","affiliation":[{"name":"Academy of Wellness and Human Development, Faculty of Arts and Social Sciences, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ip","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Torbahn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Paracelsus Medical University, Klinikum N\u00fcrnberg, Universit\u00e4tsklinik der Paracelsus Medizinischen Privatuniversit\u00e4t N\u00fcrnberg, Nuremberg, Germany"},{"name":"Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria"},{"name":"Obesity research unit, Paracelsus Medical University, Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weghuber","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria"},{"name":"Obesity research unit, Paracelsus Medical University, Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Y.","family":"Huang","sequence":"additional","affiliation":[{"name":"Academy of Wellness and Human Development, Faculty of Arts and Social Sciences, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China"},{"name":"Dr Stephen Hui Research Centre for Physical Recreation and Wellness, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn T.","family":"Tam","sequence":"additional","affiliation":[{"name":"Academy of Wellness and Human Development, Faculty of Arts and Social Sciences, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China"},{"name":"Dr Stephen Hui Research Centre for Physical Recreation and Wellness, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10431","key":"poi260032r1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"poi260032r3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.18148","article-title":"Cardiovascular risk factors in childhood and adulthood and cardiovascular disease in middle age.","volume":"7","author":"Kartiosuo","year":"2024","journal-title":"JAMA Network Open"},{"issue":"6","key":"poi260032r4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/joim.13547","article-title":"Pediatric obesity\u2014long-term consequences and effect of weight loss.","volume":"292","author":"Marcus","year":"2022","journal-title":"J Intern Med"},{"issue":"3","key":"poi260032r5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003078","article-title":"Association of childhood obesity with risk of early all-cause and cause-specific mortality: a Swedish prospective cohort study.","volume":"17","author":"Lindberg","year":"2020","journal-title":"PLoS Med"},{"issue":"1","key":"poi260032r6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-023-00435-4","article-title":"Child and adolescent obesity.","volume":"9","author":"Lister","year":"2023","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"poi260032r7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.tem.2015.08.008","article-title":"The genetics of pediatric obesity.","volume":"26","author":"Chesi","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"poi260032r8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1399-5448.2007.00337.x","article-title":"An overview of pediatric obesity.","volume":"8","author":"Lee","year":"2007","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"poi260032r10","article-title":"Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity.","volume":"151","author":"Hampl","year":"2023","journal-title":"Pediatrics"},{"issue":"3","key":"poi260032r11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1001\/jama.2024.11146","article-title":"Interventions for high body mass index in children and adolescents: US Preventive Services Task Force recommendation statement.","volume":"332","author":"Nicholson","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"poi260032r12","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3390\/nu12082208","article-title":"Effects of lifestyle modification interventions to prevent and manage child and adolescent obesity: a systematic review and meta-analysis.","volume":"12","author":"Salam","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"poi260032r13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001872.pub2","article-title":"Interventions for treating obesity in children.","author":"Oude Luttikhuis","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"poi260032r14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/15374416.2014.963854","article-title":"Evidence update on the treatment of overweight and obesity in children and adolescents.","volume":"44","author":"Altman","year":"2015","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"10","key":"poi260032r15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nrendo.2013.149","article-title":"Lifestyle intervention in childhood obesity: changes and challenges.","volume":"9","author":"Reinehr","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"poi260032r16","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/oby.24107","article-title":"Improving access to first-line treatment for pediatric obesity: lessons from the dissemination of SmartMoves.","volume":"32","author":"Finn","year":"2024","journal-title":"Obesity (Silver Spring)"},{"issue":"9727","key":"poi260032r17","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S0140-6736(10)60171-7","article-title":"Childhood obesity.","volume":"375","author":"Han","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"poi260032r18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s13679-024-00566-z","article-title":"Update on pediatric anti-obesity medications\u2014current landscape and approach to prescribing.","volume":"13","author":"Ahn","year":"2024","journal-title":"Curr Obes Rep"},{"issue":"3","key":"poi260032r19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-044982","article-title":"Metformin treatment of pediatric obesity.","volume":"147","author":"Raman","year":"2021","journal-title":"Pediatrics"},{"issue":"4","key":"poi260032r20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamapediatrics.2013.1045","article-title":"The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trial.","volume":"167","author":"Kelly","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"7","key":"poi260032r21","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3390\/ph17070828","article-title":"Comparative efficacy and safety of glucagon-like peptide-1 receptor agonists in children and adolescents with obesity or overweight: a systematic review and network meta-analysis.","volume":"17","author":"Liu","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"15","key":"poi260032r22","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1161\/CIR.0b013e3182a5cfb3","article-title":"Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association.","volume":"128","author":"Kelly","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"poi260032r23","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1542\/peds.2015-1558","article-title":"The role of the pediatrician in primary prevention of obesity.","volume":"136","author":"Daniels","year":"2015","journal-title":"Pediatrics"},{"issue":"11","key":"poi260032r24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"poi260032r25","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"poi260032r26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060641","article-title":"Executive summary: clinical practice guideline for the evaluation and treatment of children and adolescents with obesity.","volume":"151","author":"Hampl","year":"2023","journal-title":"Pediatrics"},{"issue":"3","key":"poi260032r27","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity\u2014assessment, treatment, and prevention: an Endocrine Society clinical practice guideline.","volume":"102","author":"Styne","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"poi260032r28","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1001\/jama.2017.0332","article-title":"Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force.","volume":"317","author":"O\u2019Connor","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"poi260032r29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jama.2024.6739","article-title":"Interventions for weight management in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"332","author":"O\u2019Connor","year":"2024","journal-title":"JAMA"},{"key":"poi260032r33","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"poi260032r34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/bmjebm-2022-112102","article-title":"Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane.","volume":"28","author":"Flemyng","year":"2023","journal-title":"BMJ Evid Based Med"},{"issue":"2","key":"poi260032r36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/biom.12762","article-title":"A matrix-based method of moments for fitting multivariate network meta-analysis models with multiple outcomes and random inconsistency effects.","volume":"74","author":"Jackson","year":"2018","journal-title":"Biometrics"},{"issue":"2","key":"poi260032r37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"poi260032r38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v077.b02","article-title":"Ggplot2-elegant graphics for data analysis.","volume":"77","author":"G\u00f3mez-Rubio","year":"2017","journal-title":"J Stat Softw"},{"issue":"7-8","key":"poi260032r39","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis.","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"issue":"4","key":"poi260032r40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis.","volume":"3","author":"van Valkenhoef","year":"2012","journal-title":"Res Synth Methods"},{"issue":"4","key":"poi260032r41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis.","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"issue":"5","key":"poi260032r42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa2204601","article-title":"Once-weekly dulaglutide for the treatment of youths with type 2 diabetes.","volume":"387","author":"Arslanian","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"poi260032r43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1515\/JPEM.2008.21.4.339","article-title":"Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial.","volume":"21","author":"Atabek","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"poi260032r44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000275888","article-title":"Effect of individualized exercise training combined with diet restriction on inflammatory markers and IGF-1\/IGFBP-3 in obese children.","volume":"56","author":"Ben Ounis","year":"2010","journal-title":"Ann Nutr Metab"},{"issue":"6","key":"poi260032r45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1399-5448.2008.00434.x","article-title":"Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.","volume":"9","author":"Burgert","year":"2008","journal-title":"Pediatr Diabetes"},{"issue":"12","key":"poi260032r46","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12690","article-title":"Increased dairy product consumption as part of a diet and exercise weight management program improves body composition in adolescent females with overweight and obesity: a randomized controlled trial.","volume":"15","author":"Calleja","year":"2020","journal-title":"Pediatr Obes"},{"issue":"1","key":"poi260032r47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1399-5448.2009.00512.x","article-title":"Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.","volume":"11","author":"Casteels","year":"2010","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"poi260032r48","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1515\/jpem.2010.168","article-title":"Effects of a structured exercise program on insulin resistance, inflammatory markers, and physical fitness in obese Korean children.","volume":"23","author":"Chae","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"poi260032r49","first-page":"12","article-title":"Lifestyle intervention in obese Chinese adolescents with nonalcoholic fatty liver disease: a randomized controlled study.","volume":"24","author":"Chan","year":"2018","journal-title":"Hong Kong Med J"},{"issue":"23","key":"poi260032r50","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1001\/jama.293.23.2873","article-title":"Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.","volume":"293","author":"Chanoine","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"poi260032r51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/17477166.2010.519387","article-title":"Early weight loss and outcome at 1 year in obese adolescents treated with orlistat or placebo.","volume":"6","author":"Chanoine","year":"2011","journal-title":"Int J Pediatr Obes"},{"issue":"1","key":"poi260032r52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12020-009-9196-9","article-title":"Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents but did not improve insulin resistance.","volume":"36","author":"Clarson","year":"2009","journal-title":"Endocrine"},{"key":"poi260032r53","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jpeds.2016.10.076","article-title":"Liraglutide in an adolescent population with obesity: a randomized, double-blind, placebo-controlled 5-week trial to assess safety, tolerability, and pharmacokinetics of liraglutide in adolescents aged 12-17 years.","volume":"181","author":"Danne","year":"2017","journal-title":"J Pediatr"},{"issue":"3","key":"poi260032r54","doi-asserted-by":"publisher","first-page":"e611","DOI":"10.1542\/peds.2011-0863","article-title":"A primary care-based, multicomponent lifestyle intervention for overweight adolescent females.","volume":"129","author":"DeBar","year":"2012","journal-title":"Pediatrics"},{"issue":"5","key":"poi260032r55","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/oby.23395","article-title":"Exenatide for weight-loss maintenance in adolescents with severe obesity: a randomized, placebo-controlled trial.","volume":"30","author":"Fox","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"poi260032r56","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in 2 randomized, placebo-controlled clinical trials.","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"poi260032r57","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/dom.13910","article-title":"A randomized, double-blind, placebo-controlled, pharmacokinetic and pharmacodynamic study of a fixed-dose combination of phentermine\/topiramate in adolescents with obesity.","volume":"22","author":"Hsia","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"poi260032r58","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1053\/meta.2001.28078","article-title":"Beneficial effects of metformin in normoglycemic morbidly obese adolescents.","volume":"50","author":"Kay","year":"2001","journal-title":"Metabolism"},{"issue":"2","key":"poi260032r59","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/oby.2011.337","article-title":"Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study.","volume":"20","author":"Kelly","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"22","key":"poi260032r60","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"A randomized, controlled trial of liraglutide for adolescents with obesity.","volume":"382","author":"Kelly","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"poi260032r61","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200014","article-title":"Phentermine\/topiramate for the treatment of adolescent obesity.","volume":"1","author":"Kelly","year":"2022","journal-title":"NEJM Evid"},{"issue":"1","key":"poi260032r62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41387-018-0057-6","article-title":"Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study.","volume":"8","author":"Lentferink","year":"2018","journal-title":"Nutr Diabetes"},{"issue":"21","key":"poi260032r63","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1001\/jama.2015.16174","article-title":"Effect of metformin added to insulin on glycemic control among overweight\/obese adolescents with type 1 diabetes: a randomized clinical trial.","volume":"314","author":"Libman","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"poi260032r64","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jshs.2013.05.001","article-title":"A 6-week diet and exercise intervention alters metabolic syndrome risk factors in obese Chinese children aged 11-13 years.","volume":"2","author":"Luo","year":"2013","journal-title":"J Sport Health Sci"},{"issue":"1","key":"poi260032r65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4158\/EP.12.1.18","article-title":"Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents.","volume":"12","author":"Maahs","year":"2006","journal-title":"Endocr Pract"},{"issue":"5","key":"poi260032r66","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12495","article-title":"Liraglutide effects in a paediatric (7-11 y) population with obesity: a randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics.","volume":"14","author":"Mastrandrea","year":"2019","journal-title":"Pediatr Obes"},{"issue":"3","key":"poi260032r67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5114\/pq.2020.100292","article-title":"Effect of a diet program and aerobic exercise in class II and class III obese children with chronic kidney disease.","volume":"29","author":"Morgan","year":"2021","journal-title":"Physiother Q"},{"issue":"1","key":"poi260032r68","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1399-5448.2008.00450.x","article-title":"Treatment of nonalcoholic fatty liver disease with metformin vs lifestyle intervention in insulin-resistant adolescents.","volume":"10","author":"Nadeau","year":"2009","journal-title":"Pediatr Diabetes"},{"issue":"12","key":"poi260032r69","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s00431-004-1534-6","article-title":"Addition of orlistat to conventional treatment in adolescents with severe obesity.","volume":"163","author":"Ozkan","year":"2004","journal-title":"Eur J Pediatr"},{"issue":"2","key":"poi260032r70","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/chi.2016.0192","article-title":"Evaluating the efficacy of the feeding exercise randomized trial in overweight and obese adolescents.","volume":"13","author":"Patsopoulou","year":"2017","journal-title":"Child Obes"},{"issue":"3","key":"poi260032r71","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1139\/apnm-2019-0137","article-title":"Effects of high-intensity interval training and nutrition advice on cardiometabolic markers and aerobic fitness in adolescent girls with obesity.","volume":"45","author":"Plavsic","year":"2020","journal-title":"Appl Physiol Nutr Metab"},{"issue":"5","key":"poi260032r72","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1249\/MSS.0b013e31823cef5e","article-title":"Lifestyle intervention improves fitness independent of metformin in obese adolescents.","volume":"44","author":"Rynders","year":"2012","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"poi260032r73","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2337\/dc13-1571","article-title":"Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial.","volume":"37","author":"Savoye","year":"2014","journal-title":"Diabetes Care"},{"issue":"7","key":"poi260032r74","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJMoa1903822","article-title":"Liraglutide in children and adolescents with type 2 diabetes.","volume":"381","author":"Tamborlane","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"poi260032r75","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2016.37","article-title":"Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.","volume":"6","author":"van der Aa","year":"2016","journal-title":"Nutr Diabetes"},{"issue":"10","key":"poi260032r76","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3748\/wjg.14.1598","article-title":"Effect of lifestyle intervention on nonalcoholic fatty liver disease in Chinese obese children.","volume":"14","author":"Wang","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"7","key":"poi260032r77","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12624","article-title":"A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity.","volume":"15","author":"Weghuber","year":"2020","journal-title":"Pediatr Obes"},{"issue":"24","key":"poi260032r78","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity.","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"poi260032r79","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1530\/EJE-10-0570","article-title":"Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.","volume":"163","author":"Wiegand","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"poi260032r80","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF03327547","article-title":"Efficacy of an internet-based behavioral weight loss program for overweight adolescent African American girls.","volume":"10","author":"Williamson","year":"2005","journal-title":"Eat Weight Disord"},{"issue":"2","key":"poi260032r81","first-page":"116","article-title":"Metformin extended-release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up.","volume":"164","author":"Wilson","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"12","key":"poi260032r82","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/oby.22300","article-title":"Effects of a community-based diabetes prevention program for Latino youth with obesity: a randomized controlled trial.","volume":"26","author":"Soltero","year":"2018","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"poi260032r84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0314787","article-title":"Pharmacological interventions for addressing pediatric and adolescent obesity: a systematic review and network meta-analysis.","volume":"20","author":"Yang","year":"2025","journal-title":"PLoS One"},{"issue":"10","key":"poi260032r85","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13946","article-title":"Efficacy and safety of pharmacological interventions in managing cardiometabolic risk factors in youth living with overweight and obesity: a systematic review and network meta-analysis.","volume":"26","author":"Faghfouri","year":"2025","journal-title":"Obes Rev"},{"issue":"10","key":"poi260032r86","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1111\/dom.15777","article-title":"Glucagon-like peptide-1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity: a systematic review and network meta-analysis.","volume":"26","author":"Shamim","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"poi260032r87","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/jcm12010145","article-title":"Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus.","volume":"12","author":"Gorgojo-Mart\u00ednez","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"poi260032r88","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00007256-200333010-00003","article-title":"Effect of endurance exercise on autonomic control of heart rate.","volume":"33","author":"Carter","year":"2003","journal-title":"Sports Med"},{"issue":"5","key":"poi260032r89","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13428","article-title":"Resistance training effectiveness on body composition and body weight outcomes in individuals with overweight and obesity across the lifespan: a systematic review and meta-analysis.","volume":"23","author":"Lopez","year":"2022","journal-title":"Obes Rev"},{"issue":"9","key":"poi260032r90","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/oby.23194","article-title":"Addressing psychosocial health in the treatment and care of adolescents with obesity.","volume":"29","author":"Jebeile","year":"2021","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"poi260032r91","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/children10071230","article-title":"Lifestyle and pharmacological interventions and treatment indications for the management of obesity in children and adolescents.","volume":"10","author":"Herouvi","year":"2023","journal-title":"Children (Basel)"},{"issue":"1","key":"poi260032r92","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/cen.15133","article-title":"Antiobesity medication in the management of children and adolescents with obesity: recent developments and research gaps.","volume":"102","author":"Torbahn","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 4","key":"poi260032r93","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13256","article-title":"Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: an overview of 12 systematic reviews and 149 studies.","volume":"22","author":"Bellicha","year":"2021","journal-title":"Obes Rev"},{"issue":"1","key":"poi260032r94","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/325464","article-title":"Changes in body composition, cardiovascular disease risk factors, and eating behavior after an intensive lifestyle intervention with high volume of physical activity in severely obese subjects: a prospective clinical controlled trial.","volume":"2013","author":"Danielsen","year":"2013","journal-title":"J Obes"},{"issue":"3","key":"poi260032r95","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3945\/an.116.014506","article-title":"Preserving healthy muscle during weight loss.","volume":"8","author":"Cava","year":"2017","journal-title":"Adv Nutr"},{"issue":"16","key":"poi260032r96","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.124.067676","article-title":"Muscle mass and glucagon-like peptide-1 receptor agonists: adaptive or maladaptive response to weight loss?","volume":"150","author":"Linge","year":"2024","journal-title":"Circulation"},{"key":"poi260032r97","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis.","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"issue":"1","key":"poi260032r98","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/dom.16012","article-title":"Characterizing body composition modifying effects of a glucagon-like peptide 1 receptor-based agonist: a meta-analysis.","volume":"27","author":"Jiao","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"poi260032r100","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.clnu.2019.04.012","article-title":"Low muscle mass and strength in pediatrics patients: why should we care?","volume":"38","author":"Orsso","year":"2019","journal-title":"Clin Nutr"},{"issue":"10","key":"poi260032r101","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1519\/JSC.0000000000003991","article-title":"Metabolic adaptations to weight loss: a brief review.","volume":"36","author":"Mart\u00ednez-G\u00f3mez","year":"2022","journal-title":"J Strength Cond Res"},{"issue":"17","key":"poi260032r102","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-term persistence of hormonal adaptations to weight loss.","volume":"365","author":"Sumithran","year":"2011","journal-title":"N Engl J Med"},{"key":"poi260032r103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jshs.2024.101008","article-title":"Comparative effectiveness of lifestyle interventions on children\u2019s body composition management: a systematic review and network meta-analysis.","volume":"14","author":"Su","year":"2025","journal-title":"J Sport Health Sci"},{"issue":"12","key":"poi260032r104","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1210\/jc.2006-2409","article-title":"Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials.","volume":"93","author":"McGovern","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"poi260032r105","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.4331","article-title":"Interventions for childhood central obesity: a systematic review and meta-analysis.","volume":"8","author":"Aychiluhm","year":"2025","journal-title":"JAMA Netw Open"},{"key":"poi260032r106","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1290184","article-title":"Exenatide for obesity in children and adolescents: systematic review and meta-analysis.","volume":"15","author":"Chen","year":"2024","journal-title":"Front Pharmacol"},{"issue":"12","key":"poi260032r107","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1210\/jc.2006-2411","article-title":"Clinical review: behavioral interventions to prevent childhood obesity: a systematic review and meta-analyses of randomized trials.","volume":"93","author":"Kamath","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"poi260032r9","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2016.09.017","volume-title":"Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment","author":"Kumar","year":"2017"},{"key":"poi260032r30","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Chandler","year":"2019"},{"key":"poi260032r31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/9781119536604.ch6","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"poi260032r35","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team R","year":"2020"},{"key":"poi260032r83","volume-title":"Wegovy (Semaglutide) Injection, for Subcutaneous Use","author":"U.S. Food and Drug Administration","year":"2025"},{"key":"poi260032r99","author":"Hjelmes\u00e6th","year":"2025"},{"key":"poi260032r2","unstructured":"World Obesity Federation Global Obesity Observatory. World Obesity Atlas 2023. Accessed June 20, 2025. https:\/\/data.worldobesity.org\/publications\/?cat=19"},{"key":"poi260032r32","unstructured":"Rohatgi? A. WebPlotDigitizer. Accessed July 10, 2025. https:\/\/apps.automeris.io\/wpd\/"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2850145\/jamapediatrics_wan_2026_oi_260032_1787759721.16707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:01:31Z","timestamp":1788879691000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2850145"}},"subtitle":["A Systematic Review and Network Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":107,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.2248","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}